Marietta Wealth Management LLC Acquires 234 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Marietta Wealth Management LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 10,999 shares of the healthcare conglomerate’s stock after purchasing an additional 234 shares during the period. Marietta Wealth Management LLC’s holdings in UnitedHealth Group were worth $3,857,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of UNH. Alliancebernstein L.P. grew its holdings in UnitedHealth Group by 5.2% during the fourth quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock worth $4,027,639,000 after purchasing an additional 569,142 shares during the period. Findlay Park Partners LLP grew its holdings in UnitedHealth Group by 69.0% during the third quarter. Findlay Park Partners LLP now owns 1,225,000 shares of the healthcare conglomerate’s stock worth $381,918,000 after purchasing an additional 500,000 shares during the period. First Trust Advisors LP grew its holdings in UnitedHealth Group by 402.0% during the fourth quarter. First Trust Advisors LP now owns 521,127 shares of the healthcare conglomerate’s stock worth $182,749,000 after purchasing an additional 417,327 shares during the period. Morgan Stanley grew its holdings in UnitedHealth Group by 4.9% during the third quarter. Morgan Stanley now owns 7,003,292 shares of the healthcare conglomerate’s stock worth $2,183,416,000 after purchasing an additional 325,936 shares during the period. Finally, CIBC Private Wealth Group LLC grew its holdings in UnitedHealth Group by 25.5% during the third quarter. CIBC Private Wealth Group LLC now owns 1,579,134 shares of the healthcare conglomerate’s stock worth $492,232,000 after purchasing an additional 321,008 shares during the period. Institutional investors and hedge funds own 86.03% of the company’s stock.

UNH has been the subject of a number of research analyst reports. Cantor Fitzgerald boosted their price objective on UnitedHealth Group from $360.00 to $375.00 and gave the stock an “overweight” rating in a report on Wednesday, December 2nd. Credit Suisse Group boosted their price objective on UnitedHealth Group from $355.00 to $395.00 and gave the stock an “average” rating in a report on Thursday, November 5th. JPMorgan Chase & Co. boosted their price objective on UnitedHealth Group from $360.00 to $430.00 in a report on Wednesday, December 2nd. Raymond James boosted their price objective on UnitedHealth Group from $355.00 to $405.00 and gave the stock a “strong-buy” rating in a report on Wednesday, December 2nd. Finally, Mizuho boosted their price objective on UnitedHealth Group from $361.00 to $380.00 and gave the stock a “buy” rating in a report on Monday, November 9th. Five equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $387.82.

UNH traded up $4.50 during trading on Tuesday, hitting $332.14. 58,965 shares of the stock traded hands, compared to its average volume of 3,453,442. UnitedHealth Group Incorporated has a twelve month low of $187.72 and a twelve month high of $367.95. The company has a market cap of $315.14 billion, a price-to-earnings ratio of 18.82, a PEG ratio of 1.55 and a beta of 0.74. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82. The business has a 50 day moving average price of $341.25 and a 200 day moving average price of $330.10.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 19th. The healthcare conglomerate reported $2.52 EPS for the quarter, beating the consensus estimate of $2.39 by $0.13. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business had revenue of $65.47 billion during the quarter, compared to the consensus estimate of $64.98 billion. During the same period in the previous year, the business earned $3.90 earnings per share. The company’s revenue was up 7.5% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 16.75 earnings per share for the current year.

In other news, Director Richard T. Burke sold 5,000 shares of the company’s stock in a transaction on Thursday, February 11th. The shares were sold at an average price of $335.80, for a total transaction of $1,679,000.00. Following the completion of the transaction, the director now directly owns 153,953 shares in the company, valued at $51,697,417.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 619 shares of the company’s stock in a transaction on Tuesday, February 9th. The stock was sold at an average price of $323.90, for a total transaction of $200,494.10. Following the transaction, the chief accounting officer now owns 31,908 shares of the company’s stock, valued at $10,335,001.20. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 37,293 shares of company stock valued at $12,886,401. Company insiders own 0.80% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Further Reading: Pattern Day Trader – What is the PDT Rule?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.